<DOC>
	<DOCNO>NCT02150863</DOCNO>
	<brief_summary>This project aim treat field cancerization ( pre-skin cancer ) manner reduce future pre-skin cancer non-melanoma skin cancer patient significant photodamage . This 3 year prospective , randomize , control comparison single treatment carbon dioxide laser resurface vs. carbon dioxide resurface plus autologous epidermal skin graft non sun expose site vs. control . Thirty subject receive treatment modality . The primary measure efficacy ( ) count number actinic keratosis non melanoma skin cancer , ( b ) blind evaluation severity standard digital photograph take treatment , ( c ) change histology treatment . Safety measure include ( ) pain , ( b ) scarring , ( c ) wound healing , ( ) infection</brief_summary>
	<brief_title>Treatment Field Cancerization Reduction Tumor Burden - A Prospective Study</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>Inclusion criterion 1 . Subjects age 18 85 year , male female . 2 . Subjects least 4 clinically diagnose actinic keratoses ( AKs ) per treatment site ( 200 sq cm ) , exclude face neck 3 . Subjects history least 1 nonmelanoma skin cancer within past year 4 . Willingness participate study 5 . Informed consent agreement sign subject 6 . Willingness follow treatment schedule post treatment care requirement 7 . Willingness use topical systemic ( oral ) TREATMENT medication include imiquimod , 5Fluorouracil , photodynamic therapy , treatment period . 8 . Has treatment AKs treatment area 4 week prior enrollment Exclusion criterion 1 . Subjects active skin cancer treatment area . Once nonmelanoma skin cancer treat , subject immediately enrol . 2 . Infection area treat 3 . An open wound area treat 4 . Presence suntan area treat , active tanning study 5 . Subjects take medication know induce photosensitivity previous 3 month 6 . The patient contraindication use carbon dioxide laser , include limited , intake isotretinoin past 12 month ; patient reduce adnexal structure ( eg , scleroderma , irradiation burn ) ; patient history vitiligo psoriasis ( risk Koebnerization ) ; history keloids/hypertrophic scarring . 7 . Subject unable comply treatment , home care followup visit 8 . Subject pregnant breast feed 9 . Prior use topical retinoids , 5 fluorouracil , imiquimod treat area within one month initial treatment 10 . Prior skin treatment laser device treat area within two month initial treatment course study ; 11 . Adverse reaction compound external agent ( e.g. , gel , lotion anesthetic cream ) require use study , alternative say agent exists ; 12 . Concurrent inflammatory skin condition , include , limited , eczema , contact dermatitis severity ; 13 . Active Herpes Simplex time treatment ; 14 . Multiple dysplastic nevi area treat ; 15 . Having bleed disorder take anticoagulation medication , include heavy use aspirin , manner allow minimum 10 day washout period prior treatment ( per patient 's physician discretion ) ; 16 . Significant concurrent illness , uncontrolled diabetes , ( i.e. , disease state opinion Investigator would interfere anesthesia , treatment , heal process ) ; 17 . Mentally incompetent , prisoner evidence active substance alcohol abuse ; 18 . Any condition , Investigator 's opinion , would make unsafe ( subject study personnel ) treat subject part research study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>actinic keratosis</keyword>
	<keyword>field cancerization</keyword>
	<keyword>organ transplant patient</keyword>
</DOC>